Turnstone Biologics Corp. Capital Expenditures
Turnstone Biologics Corp. reported Capital Expenditures of $229.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-08-08
- Turnstone Biologics Corp. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was -$19.00K.
- Turnstone Biologics Corp. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was -$1.00K, a 100.39% decline year-over-year.
- Turnstone Biologics Corp. payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $105.00K, a 4.55% decline year-over-year.
- Turnstone Biologics Corp. payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $144.00K, a 83.64% decline year-over-year.
- Turnstone Biologics Corp. payments to acquire property, plant, and equipment for fiscal 2024 was $229.00K, a 81.67% decline from fiscal 2023.
- Turnstone Biologics Corp. payments to acquire property, plant, and equipment for fiscal 2023 was $1.25M, a 75.84% decline from fiscal 2022.
- Turnstone Biologics Corp. payments to acquire property, plant, and equipment for fiscal 2022 was $5.17M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$20.00K derived: sum of 2 quarters · filed 2025-03-31 | $85.00K derived: sum of 3 quarters · filed 2025-08-08 | $229.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $104.00K derived: sum of 2 quarters · filed 2025-08-08 | $248.00K 10-Q · filed 2024-11-12 | $248.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $249.00K 10-Q · filed 2025-08-08 | $249.00K derived: sum of 3 quarters · filed 2025-08-08 | $508.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $144.00K 10-Q · filed 2025-05-09 | $144.00K derived: sum of 2 quarters · filed 2025-05-09 | $403.00K derived: sum of 3 quarters · filed 2025-05-09 | $513.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $259.00K derived: sum of 2 quarters · filed 2025-03-31 | $369.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.25M 10-K · filed 2025-03-31 |
| 2023-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $369.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.25M 10-Q · filed 2024-11-12 | $1.35M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $990.00K 10-Q · filed 2024-08-14 | $1.09M derived: sum of 3 quarters · filed 2024-08-14 | $3.40M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $880.00K 10-Q · filed 2024-05-13 | $982.00K derived: sum of 2 quarters · filed 2024-05-13 | $3.29M derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $2.41M derived: sum of 2 quarters · filed 2024-03-22 | $5.17M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.07M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $2.76M 10-Q · filed 2023-09-01 |